NYSE: ALBAlbemarle Corporation

    Albemarle Q3 2026 Results: Net Income $255 Million on Revenue of $1.55 Billion

    • US stocks
    • Earnings
    • Materials
    A chemical plant at night with lit pipes, towers and steam rising from processing units
    Rjendrzejewski, via Wikimedia Commons (CC0). Illustrative image.

    Albemarle (NYSE: ALB) reported results for the third quarter ended 30 Sep 2026, with GAAP revenue of $1.55 billion and GAAP net income attributable to common shareholders of $255.1 million, and it said on 4 Nov 2026 that it had updated parts of its 2026 outlook. Diluted EPS was $2.15 on a GAAP basis, and the company's adjusted diluted EPS, a measure it defines itself, was $2.58.

    Key highlights

    • Revenue (GAAP): $1.55 billion, up 18.8% YoY
    • Net income attributable to common shareholders (GAAP): $255.1 million, against -$202.4 million a year earlier
    • Diluted EPS (GAAP): $2.15, against -$1.72 a year earlier
    • Adjusted diluted EPS (company-defined): $2.58

    Summary

    Consolidated (GAAP) $ million
    ParticularsQ3 2026Q3 2025YoY
    Revenue1,553.11,307.8+18.8%
    148.2-217.0n/a
    255.1-202.4n/a
    Diluted EPS ($)2.15-1.72n/a

    Figures are in $ million except EPS; YoY compares with Q3 2025. Q3 2026 is the three months to 30 Sep 2026, from the company's release. Earlier quarters are the release's own comparatives, not cross-checked against SEC XBRL data. GAAP; net income attributable to the company; diluted EPS. Changes and margins computed by Blacklitt.

    The table shows GAAP revenue of $1.55 billion, up 18.8% from $1.31 billion a year earlier. GAAP operating income was $148.2 million, against an operating loss of $217.0 million a year earlier.

    The GAAP operating margin was 9.5%, against -16.6% a year earlier. The GAAP net income margin was 16.4%, against -15.5% a year earlier.

    Adjusted figures exclude items the company names

    Adjusted net income attributable to Albemarle was $353.6 million, or $2.58 per diluted share, against GAAP net income attributable to Albemarle of $296.8 million. Adjusted EBITDA was $645.5 million, up 186.1% from $225.6 million a year earlier, and the company calls this a company-defined measure.

    The company says its adjusted figures exclude items it treats as non-recurring or unusual. The release names an $8.0 million restructuring charge tied to placing Kemerton Train 1 into care and maintenance, and $11.6 million of consulting fees for a strategic cost savings initiative.

    Energy Storage and Specialties results

    Energy Storage net sales were $1.12 billion, up 57.9%. The company said the increase reflected higher pricing, with average realized price at $20.02 per kg LCE against $10.28 a year earlier, while sales volume fell to 56 kilotons LCE from 69. The company says the prior-year quarter was affected by timing events, among them inventory reductions and above-usual spodumene shipments.

    Specialties net sales were $388.6 million, up 12.7%, with adjusted EBITDA of $98.7 million, up 30.7%. The company said Specialties pricing rose 10% and volumes rose 3%.

    Outlook and cash flow

    The company now expects Specialties adjusted EBITDA of $350 million to $375 million for 2026, up from $275 million to $325 million. It expects full-year capital expenditure of $300 million to $350 million, down from approximately $500 million, and attributes the change to capital efficiency improvements and resequencing of some early-stage projects.

    Cash from operating activities was $405.8 million in the quarter. Free cash flow, a non-GAAP measure the company reports, was $325.4 million after capital expenditures of $80.4 million.

    Inference

    Diluted weighted-average common shares were 118.5 million in the quarter, against 117.7 million a year earlier, and the company's adjusted diluted share count was 137.1 million. Dividends paid to common shareholders were $143.2 million in the first nine months of 2026.

    The release does not quantify the fourth-quarter outlook; it says net sales and adjusted EBITDA are expected to decrease sequentially. The next dated step is the company's earnings call on 5 Nov 2026.

    Filed with the US SEC on . Reference: Original filing (SEC)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

    Latest posts